Chemomab Therapeutics (CMMB) Property, Plant & Equipment (Net) (2017 - 2025)

Chemomab Therapeutics (CMMB) Property, Plant & Equipment (Net) (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Chemomab Therapeutics 729.63 Mn 719.26 Mn - 176,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 176,000.00
Dec 31, 2025 176,000.00
Sep 30, 2025 188,000.00
Sep 30, 2025 188,000.00
Jun 30, 2025 217,000.00
Jun 30, 2025 217,000.00
Mar 31, 2025 237,000.00
Mar 31, 2025 237,000.00
Dec 31, 2024 250,000.00
Dec 31, 2024 250,000.00
Sep 30, 2024 262,000.00
Sep 30, 2024 262,000.00
Jun 30, 2024 276,000.00
Jun 30, 2024 276,000.00
Mar 31, 2024 289,000.00
Mar 31, 2024 289,000.00
Dec 31, 2023 303,000.00
Dec 31, 2023 303,000.00
Sep 30, 2023 319,000.00
Sep 30, 2023 319,000.00